Point-of-Care Diagnostic Systems for Infectious Diseases, e.g., Rapid Test for Periprosthetic Joint Infections
InfectoTest GmbH
Berlin (Chausseestr. 121A) · HeadquartersNew on Amplifa
About InfectoTest
InfectoTest GmbH, based in Berlin, is a biotechnology company that develops innovative Point-of-Care diagnostic systems for diagnosing infectious diseases. The focus is on implant-associated infections; the product InfectoSynovia is a bacteria-specific Point-of-Care test for diagnosing periprosthetic joint infections (PJI), which is based on an electrochemical analysis method and provides a result in under five minutes using a minimal synovial fluid sample. The company conducts research, clinical studies, and studies in the field of infectious disease diagnostics and commercializes the results. The goal is to improve the diagnostic process so that patients receive the appropriate therapy as quickly as possible. The team combines expertise in infectious disease diagnostics, laboratory and clinical research, as well as scientific, technical, and regulatory development. Collaborations include the PRO-IMPLANT Foundation; in 2024, Biocomposites made a strategic investment in the company.
- Site
- Berlin
- Processes
- Development of Point-of-Care diagnostic systems for infectious diseases, Research, clinical studies, and trials in the field of infectious disease diagnostics, Electrochemical analysis (InfectoSynovia Point-of-Care Test for PJI, diagnosis in under 5 minutes)
- Materials
- Electrochemical Point-of-Care Test (InfectoSynovia)
- Certificates
- Certificates (Source Status)
- Employees
- 2–10
- Industries
- Medical Technology/Diagnostics, Biotechnology, Cardiology, Neurology, Traumatology and Orthopedics
- 01
Research & Development
- 02
Clinical Studies and Trials
- 03
Electrochemical Analysis Methods
- 04
Commercial Utilization
Methods & Technologies
Electrochemical Point-of-Care Test (InfectoSynovia)
Electrochemical analysis of minimal synovial fluid samples for bacteria-specific PJI diagnosis in under five minutes.
Site
Berlin
DEHeadquarters, Research and Development
Diagnostic Products
Inside the production
Industries
Additional services
Reference customers
Quality
Quality management is overseen by a dedicated Quality Manager (Lora Friesen); no certificates are listed in the sources.
| Evidence | Berlin |
|---|---|
| Certificates (Source Status) |
Company History
- 2024
Strategic investment by Biocomposites in InfectoTest GmbH to support the development of InfectoSynovia, a Point-of-Care test for periprosthetic joint infections.
- 2026
Capital increases: Share capital increased to EUR 82,169.00 by resolution of 26.05.2026, registration on 16.06.2026.